Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective and Retrospective Registry and Biomarker Study to Evaluate the Natural History of Pediatric Patients With Cardiomyopathy Due to MYBPC3 Mutations

NCT05112237 is registered in ClinicalTrials.gov with Tenaya Therapeutics as lead sponsor.

NCT NCT05112237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05112237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective and Retrospective Registry and Biomarker Study to Evaluate the Natural History of Pediatric Patients With Cardiomyopathy Due to MYBPC3 Mutations
Lead sponsor
Tenaya Therapeutics
Phase
Observational
Overall status
Active, not recruiting
Start date
November 1, 2021
Completion date
June 30, 2028
Enrollment
200 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomyopathy